These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 20587408)

  • 1. Lethal breast cancer.
    O'Shaughnessy JA
    Clin Breast Cancer; 2010; 10 Suppl 1():E6-7. PubMed ID: 20587408
    [No Abstract]   [Full Text] [Related]  

  • 2. [Expression correlation of Ki67 to P53,VEGF,and C-erbB-2 genes in breast cancer and their clinical significances].
    Li BJ; Zhu ZH; Wang JY; Hou JH; Zhao JM; Zhang PY; Yao GY; Wang X; Long H; Yang MT; Rong TH
    Ai Zheng; 2004 Oct; 23(10):1176-9. PubMed ID: 15473930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line.
    Ethier SP; Kokeny KE; Ridings JW; Dilts CA
    Cancer Res; 1996 Feb; 56(4):899-907. PubMed ID: 8631031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian "tumor of breast tissue: incidence, genetics, and environmental risk factors" study.
    Langsenlehner U; Wolf G; Langsenlehner T; Gerger A; Hofmann G; Clar H; Wascher TC; Paulweber B; Samonigg H; Krippl P; Renner W
    Breast Cancer Res Treat; 2008 May; 109(2):297-304. PubMed ID: 17636397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of estrogen, tamoxifen and epidermal growth factor on the transcriptional regulation of vascular endothelial growth factor in breast cancer cells.
    Lee JE; Chung KW; Han W; Kim SW; Kim SW; Shin HJ; Bae JY; Noh DY
    Anticancer Res; 2004; 24(6):3961-4. PubMed ID: 15736439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Her2 genotype and breast cancer progression in Korean women.
    An HJ; Kim NK; Oh D; Kim SH; Park MJ; Jung MY; Kang H; Kim SG; Lee KP; Lee KS
    Pathol Int; 2005 Feb; 55(2):48-52. PubMed ID: 15693849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic effects of surgery: quantitative analysis of circulating basic fibroblast growth factor (bFGF), Vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGF-beta) in patients with breast cancer who underwent limited or extended surgery.
    Curigliano G; Petit JY; Bertolini F; Colleoni M; Peruzzotti G; de Braud F; Gandini S; Giraldo A; Martella S; Orlando L; Munzone E; Pietri E; Luini A; Goldhirsch A
    Breast Cancer Res Treat; 2005 Sep; 93(1):35-40. PubMed ID: 16184456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of vascular endothelial growth factor and its receptor Flk-1/KDR in benign and malignant breast neoplasms].
    Li YJ; Wen G; Wang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):70-1, 74. PubMed ID: 19218116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of endothelial cells, central necrosis, and fibrosis are associated with aggressive inflammatory breast cancer.
    Shirakawa K; Tsuda H; Heike Y; Kato K; Asada R; Inomata M; Sasaki H; Kasumi F; Yoshimoto M; Iwanaga T; Konishi F; Terada M; Wakasugi H
    Cancer Res; 2001 Jan; 61(2):445-51. PubMed ID: 11212228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of vascular endothelial growth factors (VEGFs)-A and -B and their receptor, VEGFR-1, in invasive breast carcinoma.
    Mylona E; Alexandrou P; Giannopoulou I; Liapis G; Sofia M; Keramopoulos A; Nakopoulou L
    Gynecol Oncol; 2007 Mar; 104(3):557-63. PubMed ID: 17150246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer.
    Linderholm BK; Lindahl T; Holmberg L; Klaar S; Lennerstrand J; Henriksson R; Bergh J
    Cancer Res; 2001 Mar; 61(5):2256-60. PubMed ID: 11280795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancer.
    Vazquez-Martin A; Colomer R; Menendez JA
    Eur J Cancer; 2007 May; 43(7):1117-24. PubMed ID: 17379503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are all cancer genes equal?
    Bartek J; Lukas J
    Nature; 2001 Jun; 411(6841):1001-2. PubMed ID: 11429580
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
    Ram TG; Dilts CA; Dziubinski ML; Pierce LJ; Ethier SP
    Mol Carcinog; 1996 Mar; 15(3):227-38. PubMed ID: 8597535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer cell-derived fibroblast growth factor 2 and vascular endothelial growth factor are chemoattractants for bone marrow stromal stem cells.
    Ritter E; Perry A; Yu J; Wang T; Tang L; Bieberich E
    Ann Surg; 2008 Feb; 247(2):310-4. PubMed ID: 18216538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
    Kawai H; Li H; Chun P; Avraham S; Avraham HK
    Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells.
    Mirkin S; Wong BC; Archer DF
    Fertil Steril; 2005 Aug; 84(2):485-91. PubMed ID: 16084894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germ-line HER-2 variant and breast cancer risk by stage of disease.
    McKean-Cowdin R; Kolonel LN; Press MF; Pike MC; Henderson BE
    Cancer Res; 2001 Dec; 61(23):8393-4. PubMed ID: 11731415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor in predicting outcome in breast cancer.
    Krippl P; Langsenlehner U; Samonigg H; Renner W; Köppel H
    Clin Cancer Res; 2004 Dec; 10(24):8752-3. PubMed ID: 15623662
    [No Abstract]   [Full Text] [Related]  

  • 20. The HER2 I655V polymorphism and risk of breast cancer in women < age 40 years.
    Montgomery KG; Gertig DM; Baxter SW; Milne RL; Dite GS; McCredie MR; Giles GG; Southey MC; Hopper JL; Campbell IG
    Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1109-11. PubMed ID: 14578152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.